Freegold Ventures Limited ("Freegold") (TSX: FVL) (OTCQX: FGOVF) is pleased to announce new drill results from its Golden ...
Alignment with the FDA on the Phase 3 trial design of VCN-01 (zabilugene almadenorepvec) for treatment of metastatic pancreatic ductal ...
As recently announced, tovecimig (DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel demonstrated a highly statistically ...
Copper Giant Resources Corp. ("Copper Giant" or the "Company") (TSXV: CGNT) (OTCQB: LBCMF) (FRA: 29H0) is pleased to announce the start of the work to file a Preliminary Economic Assessment ("PEA") in ...
ZYNLONTA combo trials in r/r DLBCL, key LOTIS-5 data Q2 2026, strong ORR/CR, cash to 2028—read now. Click for this ADCT ...
Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2026 and reaffirmed its full-year 2026 financial guidance (2).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results